- Pediatric Specialty CenterSmilow Cancer Hospital at Yale New Haven35 Park StreetNew Haven, CT 06511
- Pediatric Hematology OncologyTrumbull Pediatric Specialty Center5520 Park Avenue, Ste 600Trumbull, CT 06611
- YNHCH Pediatric Specialty Center at GreenwichPediatric Specialty Center500 West Putnam Avenue, Fl 2Greenwich, CT 06830
Mary Jane Hogan, MD, MPH, FAAP
Biography
Mary Jane Hogan, MD, MPH, specializes in noncancerous conditions that affect children’s white blood cells, red blood cells, platelets and clotting factors (proteins in the blood that control bleeding). She also evaluates and treats pediatric cancers including leukemia, lymphoma tumors anywhere in the body.
A childhood cancer survivor herself, Dr. Hogan says she has long recognized the importance of family support when it comes to health care. “Although pediatric blood disorders and cancers are rare, they impact us all, which is something I think about as a parent, spouse, sister, daughter, cousin and aunt,” Dr. Hogan says.
The advances in the diagnosis, treatment and supportive care for pediatric blood disorders and cancers have been extraordinary, Dr. Hogan says. “I enjoy navigating children through and familiarizing families with these complex choices,” she says. “Working alongside pediatric health-care providers and children from newborn to 20 or older is inspiring. As a member of the Children’s Oncology Group, a national collaboration of pediatric cancer specialists, I have access to other experts who research these rare disorders so I can provide the most current treatments available.”
Dr. Hogan is an assistant clinical professor of pediatric hematology and oncology at Yale School of Medicine.
Titles
- Associate Professor of Pediatrics (Hematology/Oncology)
Education & Training
- MPHJohns Hopkins University Bloomberg School of Public Health (2010)
- Research FellowUniversity of Chicago Children’s Hospital, Chicago, IL (1998)
- FellowUniversity of Chicago Children’s Hospital (1997)
- Chief ResidentUniversity of Chicago Children’s Hospital, Chicago, IL (1994)
- ResidencyUniversity of Chicago Children's Hospital (1993)
- MDUniversity of Connecticut School of Medicine (1990)
Additional Information
- Make A Wish Foundation honoree: (2003)
- Pediatrics Post-Doctoral Research Day award: University of Chicago Hospitals (1997)
- Pediatrics Post-Doctoral Research Day award: University of Chicago Hospitals (1996)
- AB of Pediatrics, Pediatric Hematology-Oncology (2002, recertified: 2010)
- AB of Pediatrics, Pediatrics (1993, recertified: 2015)
- American Society of Pediatric Hematology Oncology (2025 - Present): ASPHO Trustee at Large
- American Society of Pediatric Hematology Oncology (2024 - Present): ASPHO and AAP Section of Hematology Oncology joint policy review group
- American Academy of Pediatrics (2024 - Present): Women's Wellbeing through Equity and Leadership
- American Society of Pediatric Hematology Oncology (2022 - 2024): Leadership Development committee
- American Society of Pediatric Hematology Oncology (2022 - 2023): Education committee
- Yale University Conflict of Interest Committee (2020 - Present): Member
- American Academy of Pediatrics (2019 - 2021): Section of Hematology Oncology Nominations committee
- Circle of Care (2019 - Present): Providing practical, emotional and financial assistance to Connecticut families, through programs and services for children with cancer
- American Academy of Pediatrics Healthychildren.org (2019 - Present): Editor of peer-reviewed, online, patient and parent education material related to hematology oncology https://www.healthychildren.org/English/health-issues/conditions/cancer/Pages/Symptoms-of-Childhood-Cancers.aspx https://www.healthychildren.org/English/health-issues/conditions/cancer/Pages/Childhood-Cancer-Coping-With-the-Diagnosis.aspx https://www.healthychildren.org/English/health-issues/conditions/cancer/Pages/Childhood-Cancer-Survivors-What-to-Expect-After-Treatment.aspx https://www.healthychildren.org/English/health-issues/conditions/cancer/Pages/neutropenia-in-children-parent-faqs.aspx
- American Society of Pediatric Hematology Oncology (2018 - 2024): Accreditation committee
- Late Toxicities After Allogeneic HCT for Non-malignant Disorders. AAP Grand Rounds March 2025; 53 (3): 35. https://doi.org/10.1542/gr.53-3-35
- Lentiviral Gene Therapy for Cerebral Adrenoleukodystrophy. AAP Grand Rounds February 2025; 53 (2): 21. https://doi.org/10.1542/gr.53-2-21
- Differentiating Immune and Inherited Thrombocytopenia. AAP Grand Rounds January 2025; 53 (1): 9. https://doi.org/10.1542/gr.53-1-09
- Weekly Efanesoctocog Alfa Prevents Bleeding in Hemophilia A. AAP Grand Rounds November 2024; 52 (5): 58. https://doi.org/10.1542/gr.52-5-58
- Presenting Signs and Symptoms of Pediatric Spinal Tumors. AAP Grand Rounds October 2024; 52 (4): 47. https://doi.org/10.1542/gr.52-4-47
- Neurocognition in Survivors of Childhood Leukemia and Severe Sepsis. AAP Grand Rounds July 2024; 52 (1): 9. https://doi.org/10.1542/gr.52-1-09
- Presenting Signs and Symptoms of Soft Tissue Sarcomas. AAP Grand Rounds June 2024; 51 (6): 71. https://doi.org/10.1542/gr.51-6-71
- Comparison of Central Venous Catheters in Pediatric Cancer. AAP Grand Rounds March 2024; 51 (3): 35. https://doi.org/10.1542/gr.51-3-35
- Chronic ITP and Sports. AAP Grand Rounds March 2024; 51 (3): 33. https://doi.org/10.1542/gr.51-3-33.
- Continuous Renal Replacement Therapy Benefits Tumor Lysis Syndrome. AAP Grand Rounds January 2024; 51 (1): 11. https://doi.org/10.1542/gr.51-1-11
- Screening Improves Outcomes for Severe Combined Immunodeficiency. AAP Grand Rounds October 2023; 50 (4): 42. https://doi.org/10.1542/gr.50-4-42
- Fitusiran Prophylaxis Reduces Bleeding in Hemophilia With Inhibitors. AAP Grand Rounds September 2023; 50 (3): 35. https://doi.org/10.1542/gr.50-3-35
- Brumer E, de Ángel Solá D, Hogan M, Chen L. Persistent Hypoxemia in an Asymptomatic 4-year-old Boy. Pediatrics In Review 2023, 44: 290-293. PMID: 37122046, DOI: 10.1542/pir.2021-005293.
- Maternal Hypertension and Thrombocytopenia in Premature Infants. AAP Grand Rounds May 2023; 49 (5): 59. https://doi.org/10.1542/gr.49-5-59
- Epistaxis and Pediatric Immune Thrombocytopenia. AAP Grand Rounds March 2023; 49 (3): 35. https://doi.org/10.1542/gr.49-3-35
- Factors Related to Delayed Diagnosis of Pediatric CNS Tumors. AAP Grand Rounds February 2023; 49 (2): 22. https://doi.org/10.1542/gr.49-2-22
- Variables Related to HPV Vaccination Rates in Teens. AAP Grand Rounds November 2022; 48 (5): 58. https://doi.org/10.1542/gr.48-5-58
- Sickle Cell Disease and Bacteremia Risk. AAP Grand Rounds June 2022; 47 (6): 67. https://doi.org/10.1542/gr.47-6-67
- Shorter Anticoagulation Yields Comparable Efficacy and Safety. AAP Grand Rounds May 2022; 47 (5): 54. https://doi.org/10.1542/gr.47-5-54
- Gene Therapy for Sickle Cell Disease. AAP Grand Rounds April 2022; 47 (4): 45. https://doi.org/10.1542/gr.47-4-45
- O’Brien S, Badawy SM, Rotz SJ, Shah MD, Makarski J, Bercovitz RS, Hogan MS, Luchtman-Jones L, Panepinto JA, Priola GM, Witmer CM, Wolfson JA, Yee M, Hicks LK. The ASH-ASPHO Choosing Wisely Campaign: 5 hematologic tests and treatments to question. Blood Advances 2022, 6: 679-685. PMID: 35072726, PMCID: PMC8791561, DOI: 10.1182/bloodadvances.2020003635.
- Hogan M. Increased Leukemia Risk in Children With Down Syndrome. AAP Grand Rounds 2021, 46: 45-45. DOI: 10.1542/gr.46-4-45.
- Hogan M. Symptoms in Infants and Toddlers With von Willebrand Disease. AAP Grand Rounds 2021, 46: 31-31. DOI: 10.1542/gr.46-3-31.
- Hogan M. Hydroxyurea Prescribing Impact in Sickle Cell Anemia. AAP Grand Rounds 2021, 46: 11-11. DOI: 10.1542/gr.46-1-11.
- O'Brien SH, Badawy SM, Rotz SJ, Shah MD, Makarski J, Bercovitz RS, Hogan M, Luchtman‐Jones L, Panepinto JA, Priola GM, Witmer CM, Wolfson JA, Yee M, Hicks LK. The ASH‐ASPHO Choosing Wisely Campaign: 5 hematologic tests and treatments to question. Pediatric Blood & Cancer 2021, 68: e28967. PMID: 34047047, DOI: 10.1002/pbc.28967.
- Hogan M. Dietary Advice Improves Non-Anemic Iron Deficiency. AAP Grand Rounds 2021, 45: 57-57. DOI: 10.1542/gr.45-5-57.
- Hogan M. Hemoglobin Transfusion Thresholds Outcomes for Preterm Infants. AAP Grand Rounds 2021, 45: 42-42. DOI: 10.1542/gr.45-4-42.
- Hogan M. Outcomes After Splenectomy for Congenital Hemolytic Anemia. AAP Grand Rounds 2021, 45: 21-21. DOI: 10.1542/gr.45-2-21.
- Hogan M. HPV Vaccine Reduces Risk of Invasive Cervical Cancer. AAP Grand Rounds 2021, 45: 11-11. DOI: 10.1542/gr.45-1-11.
- Hogan M. Isolated Neutropenia and Clinical Outcomes. AAP Grand Rounds 2020, 44: 71-71. DOI: 10.1542/gr.44-6-71.
- Hogan M. Maternal HLA Type and Fetal/Neonatal Alloimmune Thrombocytopenia. AAP Grand Rounds 2020, 44: 55-55. DOI: 10.1542/gr.44-5-55.
- Hogan M. Early Factor VIII Prophylaxis Prevents Joint Damage in Hemophilia. AAP Grand Rounds 2020, 44: 44-44. DOI: 10.1542/gr.44-4-44.
- Hogan M. Warmed Saline for Vaso-oclusive Episodes in Sickle Cell Disease. AAP Grand Rounds 2020, 44: 35-35. DOI: 10.1542/gr.44-3-35.
- Hogan M. Transplantation Outcomes in Diamond-Blackfan Anemia. AAP Grand Rounds 2020, 44: 22-22. DOI: 10.1542/gr.44-2-22.
- Hogan M. Adverse Events With Central Venous Catheters. AAP Grand Rounds 2020, 43: 56-56. DOI: 10.1542/gr.43-5-56.
- Hogan M. Risk of Second Malignancy in Survivors of Childhood Cancer. AAP Grand Rounds 2020, 43: 46-46. DOI: 10.1542/gr.43-4-46.
- Hogan M. Late Infections in Survivors of Childhood Leukemia. AAP Grand Rounds 2020, 43: 21-21. DOI: 10.1542/gr.43-2-21.
- Hogan M. Head and Neck Melanoma in Children and Young Adults. AAP Grand Rounds 2020, 43: 3-3. DOI: 10.1542/gr.43-1-3.
- Hogan M. Laboratory Values in Iron Deficiency Anemia and β-Thalassemia Trait. AAP Grand Rounds 2019, 42: 46-46. DOI: 10.1542/gr.42-4-46.
- Hogan M. Hemoglobin S Polymerization Inhibitor in Sickle Cell Disease. AAP Grand Rounds 2019, 42: 30-30. DOI: 10.1542/gr.42-3-30.
- Hogan M. Lentiviral Vector Gene Therapy for X-linked SCID. AAP Grand Rounds 2019, 42: 8-8. DOI: 10.1542/gr.42-1-8.
- Hogan M. Hydroxyurea Treatment for Sickle Cell Anemia in Africa. AAP Grand Rounds 2019, 41: 53-53. DOI: 10.1542/gr.41-5-53.
- Hogan M. Health Outcomes and Sickle Cell Trait. AAP Grand Rounds 2019, 41: 33-33. DOI: 10.1542/gr.41-3-33.
- Hogan M. Platelet Transfusion Trial in Neonatal Thrombocytopenia. AAP Grand Rounds 2019, 41: 19-19. DOI: 10.1542/gr.41-2-19.
- Hogan M. Bacteremia in Febrile Children With Sickle Cell Anemia. AAP Grand Rounds 2019, 41: 9-9. DOI: 10.1542/gr.41-1-9.
- Hogan M. Intravenous Immunoglobulin in Acute Immune Thrombocytopenia. AAP Grand Rounds 2018, 40: 65-65. DOI: 10.1542/gr.40-6-65.
- Hogan M. Late Mortality After Pediatric Autologous Blood or Marrow Transplant. AAP Grand Rounds 2018, 40: 57-57. DOI: 10.1542/gr.40-5-57.
- Hogan M. Improved Outcomes With L-Glutamine Use in Sickle Cell Disease. AAP Grand Rounds 2018, 40: 40-40. DOI: 10.1542/gr.40-4-40.
- Hogan M. Isolated Mild to Moderate Thrombocytopenia in Children. AAP Grand Rounds 2018, 40: 30-34. DOI: 10.1542/gr.40-3-30.
- Hogan M. Clinical Spectrum of Pyruvate Kinase Deficiency. AAP Grand Rounds 2018, 40: 22-22. DOI: 10.1542/gr.40-2-22.
- Hogan M, Ross WL, Balsamo L, Mitchell H, Kadan‐Lottick N. Parental perception of child vulnerability in childhood cancer survivors. Pediatric Blood & Cancer 2018, 65: e27364. PMID: 30024087, DOI: 10.1002/pbc.27364.
- Hogan M. Risk Factors for Development of Acute Chest Syndrome. AAP Grand Rounds 2018, 39: 59-59. DOI: 10.1542/gr.39-5-59.
- Hogan M. Childhood Cancer Survivors at Risk for Brain Tumors. AAP Grand Rounds 2018, 39: 33-33. DOI: 10.1542/gr.39-3-33.
- Hogan M. Bruising Patterns in Young Children With Bleeding Disorders. AAP Grand Rounds 2018, 39: 29-29. DOI: 10.1542/gr.39-3-29.
- Hogan M. Resolution Predictors of Childhood Immune Thrombocytopenia. AAP Grand Rounds 2017, 38: 52-52. DOI: 10.1542/gr.38-5-52.
- Hogan M. Emicizumab Reduces Bleeding in Hemophilia A With Inhibitors. AAP Grand Rounds 2017, 38: 44-44. DOI: 10.1542/gr.38-4-44.
- Hogan M. Higher Birth Weight Linked to Osteosarcoma Severity. AAP Grand Rounds 2017, 38: 35-35. DOI: 10.1542/gr.38-3-35.
- Hogan M. Risk Factors for Early Death in Childhood Cancer. AAP Grand Rounds 2017, 38: 23-23. DOI: 10.1542/gr.38-2-23.
- Hogan M. Congenital Cytomegalovirus Infection and Acute Lymphoblastic Leukemia. AAP Grand Rounds 2017, 37: 70-70. DOI: 10.1542/gr.37-6-70.
- Hogan M. Cancer Risk After Growth Hormone Therapy. AAP Grand Rounds 2017, 37: 71-71. DOI: 10.1542/gr.37-6-71.
- Hogan M. Management of Fetal/Neonatal Alloimmune Thrombocytopenia. AAP Grand Rounds 2017, 37: 57-57. DOI: 10.1542/gr.37-5-57.
- Hogan M. Intravenous Ferric Carboxymaltose for Iron Deficiency Anemia. AAP Grand Rounds 2017, 37: 22-22. DOI: 10.1542/gr.37-2-22.
- Hogan M. Clinical Presentation of Leukemia. AAP Grand Rounds 2016, 36: 70-70. DOI: 10.1542/gr.36-6-70.
- Hogan M. Endocrinopathies in Childhood Cancer Survivors. AAP Grand Rounds 2016, 36: 41-41. DOI: 10.1542/gr.36-4-41.
- Hogan M. Hearing Loss After Cranial Irradiation for Childhood Cancer. AAP Grand Rounds 2016, 36: 32-32. DOI: 10.1542/gr.36-3-32.
- Hogan M. Romiplostim Therapy of Immune Thrombocytopenia. AAP Grand Rounds 2016, 36: 34-34. DOI: 10.1542/gr.36-3-34.
- Hogan M. Cardiovascular Disease Risk After Adolescent & Young Adult Cancer. AAP Grand Rounds 2016, 36: 6-6. DOI: 10.1542/gr.36-1-6.
- Zweidler-McKay PA, Hogan MJ, Jubran R, Black V, Casillas J, Harper J, Malempati S, Margolin J, Felgenhauer J, Sakamoto KM, Franklin J, Shah M, Seibel N, Buchanan G, Vaiselbuh SR, Hastings C, Hilden J, Stork LC. Navigating your career path in pediatric hematology/oncology: On and off the beaten track. Pediatric Blood & Cancer 2016, 63: 1723-1730. PMID: 27295503, DOI: 10.1002/pbc.26094.
- Hogan M. Late Mortality After Childhood Cancer. AAP Grand Rounds 2016, 35: 56-56. DOI: 10.1542/gr.35-5-56.
- Hogan M. Heritable Mutations in Pediatric Cancer. AAP Grand Rounds 2016, 35: 43-43. DOI: 10.1542/gr.35-4-43.
- Hogan M. Pediatric Outcomes After Maternal Cancer During Pregnancy. AAP Grand Rounds 2016, 35: 19-19. DOI: 10.1542/gr.35-2-19.
- Hogan M. Pesticides and Childhood Cancer. AAP Grand Rounds 2015, 34: 66-66. DOI: 10.1542/gr.34-6-66.
- Hogan M. Neurocognitive Deficits After Chemotherapy. AAP Grand Rounds 2015, 34: 53-53. DOI: 10.1542/gr.34-5-53.
- Hogan M. Symptom Distress in Children With Advanced Cancer. AAP Grand Rounds 2015, 34: 42-42. DOI: 10.1542/gr.34-4-42.
- Hogan M. Pulmonary Function in Childhood Cancer Survivors. AAP Grand Rounds 2015, 34: 31-31. DOI: 10.1542/gr.34-3-31.
- Honarpisheh H, Hogan M, Rinder HM, Siddon AJ. Hemoglobinopathy Screening in a 15-Year-old Patient With Anemia. Journal Of Pediatric Hematology/Oncology 2015, 37: 472-473. PMID: 26181419, DOI: 10.1097/mph.0000000000000357.
- Hogan M. Prevalence and Burden of Morbidity in Childhood Cancer Survivors. AAP Grand Rounds 2015, 34: 21-21. DOI: 10.1542/gr.34-2-21.
- Hogan M. Screening for Steroid-Induced Hip Osteonecrosis in Leukemia. AAP Grand Rounds 2015, 33: 66-66. DOI: 10.1542/gr.33-6-66.
- Hogan M. Sun Protection Among Children of Melanoma Survivors. AAP Grand Rounds 2015, 33: 67-67. DOI: 10.1542/gr.33-6-67.
- Hogan M. Emergency Department Visits for Children With Cancer. AAP Grand Rounds 2015, 33: 56-56. DOI: 10.1542/gr.33-5-56.
- Hogan M. Cognitive Function After Hematopoietic Stem Cell Transplantation. AAP Grand Rounds 2015, 33: 34-34. DOI: 10.1542/gr.33-3-34.
- Hogan M. Burden of Central Line Infections in Hematology-Oncology Patients. AAP Grand Rounds 2015, 33: 27-27. DOI: 10.1542/gr.33-3-27.
- Hogan M. Obesity Affects Outcomes in Pediatric Leukemia. AAP Grand Rounds 2015, 33: 18-18. DOI: 10.1542/gr.33-2-18.
- Hogan M. Posttraumatic Stress in Pediatric Cancer Patients. AAP Grand Rounds 2015, 33: 6-6. DOI: 10.1542/gr.33-1-6.
- Hogan M. Late Infections in Childhood Cancer Survivors. AAP Grand Rounds 2015, 33: 5-5. DOI: 10.1542/gr.33-1-5.
- Hogan M. Oral Chemotherapy Adherence in Children With Leukemia. AAP Grand Rounds 2015, 33: 3-3. DOI: 10.1542/gr.33-1-3.
- Hogan M, Ma X, Kadan‐Lottick N. New health conditions identified at a regional childhood cancer survivor clinic visit. Pediatric Blood & Cancer 2012, 60: 682-687. PMID: 23023769, DOI: 10.1002/pbc.24360.
- Staba MJ, Wickham TJ, Kovesdi I, Hallahan DE. Modifications of the fiber in adenovirus vectors increase tropism for malignant glioma models. Cancer Gene Therapy 2000, 7: 13-9. PMID: 10678351, DOI: 10.1038/sj.cgt.7700104.
- Seetharam S, Staba MJ, Schumm LP, Schreiber K, Schreiber H, Kufe DW, Weichselbaum RR. Enhanced eradication of local and distant tumors by genetically produced interleukin-12 and radiation. International Journal Of Oncology 1999, 15: 769-73. PMID: 10493960.
- Mauceri HJ, Hanna NN, Staba MJ, Beckett MA, Kufe DW, Weichselbaum RR. Radiation-inducible gene therapy. Comptes Rendus De L'Académie Des Sciences. Série III, Sciences De La Vie 1999, 322: 225-8. PMID: 10196676.
- Hallahan DE, Staba-Hogan MJ, Virudachalam S, Kolchinsky A. X-ray-induced P-selectin localization to the lumen of tumor blood vessels. Cancer Research 1998, 58: 5216-20. PMID: 9823335.
- Mauceri HJ, Hanna NN, Beckett MA, Gorski DH, Staba MJ, Stellato KA, Bigelow K, Heimann R, Gately S, Dhanabal M, Soff GA, Sukhatme VP, Kufe DW, Weichselbaum RR. Combined effects of angiostatin and ionizing radiation in antitumour therapy. Nature 1998, 394: 287-91. PMID: 9685160, DOI: 10.1038/28412.
- Staba MJ, Mauceri HJ, Kufe DW, Hallahan DE, Weichselbaum RR. Adenoviral TNF-alpha gene therapy and radiation damage tumor vasculature in a human malignant glioma xenograft. Gene Therapy 1998, 5: 293-300. PMID: 9614548, DOI: 10.1038/sj.gt.3300594.
- Staba MJ, Goldman S, Johnson FL, Huttenlocher PR. Allogeneic bone marrow transplantation for Alexander's disease. Bone Marrow Transplantation 1997, 20: 247-9. PMID: 9257894, DOI: 10.1038/sj.bmt.1700871.
- AMA Complete Guide to Your Children’s Health.Editor Traisman ES, Asst. Editors Staba MJ, Judy KR. Random House, New York, 1999.
- Pediatric Specialty CenterSmilow Cancer Hospital at Yale New Haven35 Park StreetNew Haven, CT 06511
- Pediatric Hematology OncologyTrumbull Pediatric Specialty Center5520 Park Avenue, Ste 600Trumbull, CT 06611
- YNHCH Pediatric Specialty Center at GreenwichPediatric Specialty Center500 West Putnam Avenue, Fl 2Greenwich, CT 06830
Biography
Mary Jane Hogan, MD, MPH, specializes in noncancerous conditions that affect children’s white blood cells, red blood cells, platelets and clotting factors (proteins in the blood that control bleeding). She also evaluates and treats pediatric cancers including leukemia, lymphoma tumors anywhere in the body.
A childhood cancer survivor herself, Dr. Hogan says she has long recognized the importance of family support when it comes to health care. “Although pediatric blood disorders and cancers are rare, they impact us all, which is something I think about as a parent, spouse, sister, daughter, cousin and aunt,” Dr. Hogan says.
The advances in the diagnosis, treatment and supportive care for pediatric blood disorders and cancers have been extraordinary, Dr. Hogan says. “I enjoy navigating children through and familiarizing families with these complex choices,” she says. “Working alongside pediatric health-care providers and children from newborn to 20 or older is inspiring. As a member of the Children’s Oncology Group, a national collaboration of pediatric cancer specialists, I have access to other experts who research these rare disorders so I can provide the most current treatments available.”
Dr. Hogan is an assistant clinical professor of pediatric hematology and oncology at Yale School of Medicine.
Titles
- Associate Professor of Pediatrics (Hematology/Oncology)
Education & Training
- MPHJohns Hopkins University Bloomberg School of Public Health (2010)
- Research FellowUniversity of Chicago Children’s Hospital, Chicago, IL (1998)
- FellowUniversity of Chicago Children’s Hospital (1997)
- Chief ResidentUniversity of Chicago Children’s Hospital, Chicago, IL (1994)
- ResidencyUniversity of Chicago Children's Hospital (1993)
- MDUniversity of Connecticut School of Medicine (1990)
Additional Information
- Make A Wish Foundation honoree: (2003)
- Pediatrics Post-Doctoral Research Day award: University of Chicago Hospitals (1997)
- Pediatrics Post-Doctoral Research Day award: University of Chicago Hospitals (1996)
- AB of Pediatrics, Pediatric Hematology-Oncology (2002, recertified: 2010)
- AB of Pediatrics, Pediatrics (1993, recertified: 2015)
- American Society of Pediatric Hematology Oncology (2025 - Present): ASPHO Trustee at Large
- American Society of Pediatric Hematology Oncology (2024 - Present): ASPHO and AAP Section of Hematology Oncology joint policy review group
- American Academy of Pediatrics (2024 - Present): Women's Wellbeing through Equity and Leadership
- American Society of Pediatric Hematology Oncology (2022 - 2024): Leadership Development committee
- American Society of Pediatric Hematology Oncology (2022 - 2023): Education committee
- Yale University Conflict of Interest Committee (2020 - Present): Member
- American Academy of Pediatrics (2019 - 2021): Section of Hematology Oncology Nominations committee
- Circle of Care (2019 - Present): Providing practical, emotional and financial assistance to Connecticut families, through programs and services for children with cancer
- American Academy of Pediatrics Healthychildren.org (2019 - Present): Editor of peer-reviewed, online, patient and parent education material related to hematology oncology https://www.healthychildren.org/English/health-issues/conditions/cancer/Pages/Symptoms-of-Childhood-Cancers.aspx https://www.healthychildren.org/English/health-issues/conditions/cancer/Pages/Childhood-Cancer-Coping-With-the-Diagnosis.aspx https://www.healthychildren.org/English/health-issues/conditions/cancer/Pages/Childhood-Cancer-Survivors-What-to-Expect-After-Treatment.aspx https://www.healthychildren.org/English/health-issues/conditions/cancer/Pages/neutropenia-in-children-parent-faqs.aspx
- American Society of Pediatric Hematology Oncology (2018 - 2024): Accreditation committee
- Late Toxicities After Allogeneic HCT for Non-malignant Disorders. AAP Grand Rounds March 2025; 53 (3): 35. https://doi.org/10.1542/gr.53-3-35
- Lentiviral Gene Therapy for Cerebral Adrenoleukodystrophy. AAP Grand Rounds February 2025; 53 (2): 21. https://doi.org/10.1542/gr.53-2-21
- Differentiating Immune and Inherited Thrombocytopenia. AAP Grand Rounds January 2025; 53 (1): 9. https://doi.org/10.1542/gr.53-1-09
- Weekly Efanesoctocog Alfa Prevents Bleeding in Hemophilia A. AAP Grand Rounds November 2024; 52 (5): 58. https://doi.org/10.1542/gr.52-5-58
- Presenting Signs and Symptoms of Pediatric Spinal Tumors. AAP Grand Rounds October 2024; 52 (4): 47. https://doi.org/10.1542/gr.52-4-47
- Neurocognition in Survivors of Childhood Leukemia and Severe Sepsis. AAP Grand Rounds July 2024; 52 (1): 9. https://doi.org/10.1542/gr.52-1-09
- Presenting Signs and Symptoms of Soft Tissue Sarcomas. AAP Grand Rounds June 2024; 51 (6): 71. https://doi.org/10.1542/gr.51-6-71
- Comparison of Central Venous Catheters in Pediatric Cancer. AAP Grand Rounds March 2024; 51 (3): 35. https://doi.org/10.1542/gr.51-3-35
- Chronic ITP and Sports. AAP Grand Rounds March 2024; 51 (3): 33. https://doi.org/10.1542/gr.51-3-33.
- Continuous Renal Replacement Therapy Benefits Tumor Lysis Syndrome. AAP Grand Rounds January 2024; 51 (1): 11. https://doi.org/10.1542/gr.51-1-11
- Screening Improves Outcomes for Severe Combined Immunodeficiency. AAP Grand Rounds October 2023; 50 (4): 42. https://doi.org/10.1542/gr.50-4-42
- Fitusiran Prophylaxis Reduces Bleeding in Hemophilia With Inhibitors. AAP Grand Rounds September 2023; 50 (3): 35. https://doi.org/10.1542/gr.50-3-35
- Brumer E, de Ángel Solá D, Hogan M, Chen L. Persistent Hypoxemia in an Asymptomatic 4-year-old Boy. Pediatrics In Review 2023, 44: 290-293. PMID: 37122046, DOI: 10.1542/pir.2021-005293.
- Maternal Hypertension and Thrombocytopenia in Premature Infants. AAP Grand Rounds May 2023; 49 (5): 59. https://doi.org/10.1542/gr.49-5-59
- Epistaxis and Pediatric Immune Thrombocytopenia. AAP Grand Rounds March 2023; 49 (3): 35. https://doi.org/10.1542/gr.49-3-35
- Factors Related to Delayed Diagnosis of Pediatric CNS Tumors. AAP Grand Rounds February 2023; 49 (2): 22. https://doi.org/10.1542/gr.49-2-22
- Variables Related to HPV Vaccination Rates in Teens. AAP Grand Rounds November 2022; 48 (5): 58. https://doi.org/10.1542/gr.48-5-58
- Sickle Cell Disease and Bacteremia Risk. AAP Grand Rounds June 2022; 47 (6): 67. https://doi.org/10.1542/gr.47-6-67
- Shorter Anticoagulation Yields Comparable Efficacy and Safety. AAP Grand Rounds May 2022; 47 (5): 54. https://doi.org/10.1542/gr.47-5-54
- Gene Therapy for Sickle Cell Disease. AAP Grand Rounds April 2022; 47 (4): 45. https://doi.org/10.1542/gr.47-4-45
- O’Brien S, Badawy SM, Rotz SJ, Shah MD, Makarski J, Bercovitz RS, Hogan MS, Luchtman-Jones L, Panepinto JA, Priola GM, Witmer CM, Wolfson JA, Yee M, Hicks LK. The ASH-ASPHO Choosing Wisely Campaign: 5 hematologic tests and treatments to question. Blood Advances 2022, 6: 679-685. PMID: 35072726, PMCID: PMC8791561, DOI: 10.1182/bloodadvances.2020003635.
- Hogan M. Increased Leukemia Risk in Children With Down Syndrome. AAP Grand Rounds 2021, 46: 45-45. DOI: 10.1542/gr.46-4-45.
- Hogan M. Symptoms in Infants and Toddlers With von Willebrand Disease. AAP Grand Rounds 2021, 46: 31-31. DOI: 10.1542/gr.46-3-31.
- Hogan M. Hydroxyurea Prescribing Impact in Sickle Cell Anemia. AAP Grand Rounds 2021, 46: 11-11. DOI: 10.1542/gr.46-1-11.
- O'Brien SH, Badawy SM, Rotz SJ, Shah MD, Makarski J, Bercovitz RS, Hogan M, Luchtman‐Jones L, Panepinto JA, Priola GM, Witmer CM, Wolfson JA, Yee M, Hicks LK. The ASH‐ASPHO Choosing Wisely Campaign: 5 hematologic tests and treatments to question. Pediatric Blood & Cancer 2021, 68: e28967. PMID: 34047047, DOI: 10.1002/pbc.28967.
- Hogan M. Dietary Advice Improves Non-Anemic Iron Deficiency. AAP Grand Rounds 2021, 45: 57-57. DOI: 10.1542/gr.45-5-57.
- Hogan M. Hemoglobin Transfusion Thresholds Outcomes for Preterm Infants. AAP Grand Rounds 2021, 45: 42-42. DOI: 10.1542/gr.45-4-42.
- Hogan M. Outcomes After Splenectomy for Congenital Hemolytic Anemia. AAP Grand Rounds 2021, 45: 21-21. DOI: 10.1542/gr.45-2-21.
- Hogan M. HPV Vaccine Reduces Risk of Invasive Cervical Cancer. AAP Grand Rounds 2021, 45: 11-11. DOI: 10.1542/gr.45-1-11.
- Hogan M. Isolated Neutropenia and Clinical Outcomes. AAP Grand Rounds 2020, 44: 71-71. DOI: 10.1542/gr.44-6-71.
- Hogan M. Maternal HLA Type and Fetal/Neonatal Alloimmune Thrombocytopenia. AAP Grand Rounds 2020, 44: 55-55. DOI: 10.1542/gr.44-5-55.
- Hogan M. Early Factor VIII Prophylaxis Prevents Joint Damage in Hemophilia. AAP Grand Rounds 2020, 44: 44-44. DOI: 10.1542/gr.44-4-44.
- Hogan M. Warmed Saline for Vaso-oclusive Episodes in Sickle Cell Disease. AAP Grand Rounds 2020, 44: 35-35. DOI: 10.1542/gr.44-3-35.
- Hogan M. Transplantation Outcomes in Diamond-Blackfan Anemia. AAP Grand Rounds 2020, 44: 22-22. DOI: 10.1542/gr.44-2-22.
- Hogan M. Adverse Events With Central Venous Catheters. AAP Grand Rounds 2020, 43: 56-56. DOI: 10.1542/gr.43-5-56.
- Hogan M. Risk of Second Malignancy in Survivors of Childhood Cancer. AAP Grand Rounds 2020, 43: 46-46. DOI: 10.1542/gr.43-4-46.
- Hogan M. Late Infections in Survivors of Childhood Leukemia. AAP Grand Rounds 2020, 43: 21-21. DOI: 10.1542/gr.43-2-21.
- Hogan M. Head and Neck Melanoma in Children and Young Adults. AAP Grand Rounds 2020, 43: 3-3. DOI: 10.1542/gr.43-1-3.
- Hogan M. Laboratory Values in Iron Deficiency Anemia and β-Thalassemia Trait. AAP Grand Rounds 2019, 42: 46-46. DOI: 10.1542/gr.42-4-46.
- Hogan M. Hemoglobin S Polymerization Inhibitor in Sickle Cell Disease. AAP Grand Rounds 2019, 42: 30-30. DOI: 10.1542/gr.42-3-30.
- Hogan M. Lentiviral Vector Gene Therapy for X-linked SCID. AAP Grand Rounds 2019, 42: 8-8. DOI: 10.1542/gr.42-1-8.
- Hogan M. Hydroxyurea Treatment for Sickle Cell Anemia in Africa. AAP Grand Rounds 2019, 41: 53-53. DOI: 10.1542/gr.41-5-53.
- Hogan M. Health Outcomes and Sickle Cell Trait. AAP Grand Rounds 2019, 41: 33-33. DOI: 10.1542/gr.41-3-33.
- Hogan M. Platelet Transfusion Trial in Neonatal Thrombocytopenia. AAP Grand Rounds 2019, 41: 19-19. DOI: 10.1542/gr.41-2-19.
- Hogan M. Bacteremia in Febrile Children With Sickle Cell Anemia. AAP Grand Rounds 2019, 41: 9-9. DOI: 10.1542/gr.41-1-9.
- Hogan M. Intravenous Immunoglobulin in Acute Immune Thrombocytopenia. AAP Grand Rounds 2018, 40: 65-65. DOI: 10.1542/gr.40-6-65.
- Hogan M. Late Mortality After Pediatric Autologous Blood or Marrow Transplant. AAP Grand Rounds 2018, 40: 57-57. DOI: 10.1542/gr.40-5-57.
- Hogan M. Improved Outcomes With L-Glutamine Use in Sickle Cell Disease. AAP Grand Rounds 2018, 40: 40-40. DOI: 10.1542/gr.40-4-40.
- Hogan M. Isolated Mild to Moderate Thrombocytopenia in Children. AAP Grand Rounds 2018, 40: 30-34. DOI: 10.1542/gr.40-3-30.
- Hogan M. Clinical Spectrum of Pyruvate Kinase Deficiency. AAP Grand Rounds 2018, 40: 22-22. DOI: 10.1542/gr.40-2-22.
- Hogan M, Ross WL, Balsamo L, Mitchell H, Kadan‐Lottick N. Parental perception of child vulnerability in childhood cancer survivors. Pediatric Blood & Cancer 2018, 65: e27364. PMID: 30024087, DOI: 10.1002/pbc.27364.
- Hogan M. Risk Factors for Development of Acute Chest Syndrome. AAP Grand Rounds 2018, 39: 59-59. DOI: 10.1542/gr.39-5-59.
- Hogan M. Childhood Cancer Survivors at Risk for Brain Tumors. AAP Grand Rounds 2018, 39: 33-33. DOI: 10.1542/gr.39-3-33.
- Hogan M. Bruising Patterns in Young Children With Bleeding Disorders. AAP Grand Rounds 2018, 39: 29-29. DOI: 10.1542/gr.39-3-29.
- Hogan M. Resolution Predictors of Childhood Immune Thrombocytopenia. AAP Grand Rounds 2017, 38: 52-52. DOI: 10.1542/gr.38-5-52.
- Hogan M. Emicizumab Reduces Bleeding in Hemophilia A With Inhibitors. AAP Grand Rounds 2017, 38: 44-44. DOI: 10.1542/gr.38-4-44.
- Hogan M. Higher Birth Weight Linked to Osteosarcoma Severity. AAP Grand Rounds 2017, 38: 35-35. DOI: 10.1542/gr.38-3-35.
- Hogan M. Risk Factors for Early Death in Childhood Cancer. AAP Grand Rounds 2017, 38: 23-23. DOI: 10.1542/gr.38-2-23.
- Hogan M. Congenital Cytomegalovirus Infection and Acute Lymphoblastic Leukemia. AAP Grand Rounds 2017, 37: 70-70. DOI: 10.1542/gr.37-6-70.
- Hogan M. Cancer Risk After Growth Hormone Therapy. AAP Grand Rounds 2017, 37: 71-71. DOI: 10.1542/gr.37-6-71.
- Hogan M. Management of Fetal/Neonatal Alloimmune Thrombocytopenia. AAP Grand Rounds 2017, 37: 57-57. DOI: 10.1542/gr.37-5-57.
- Hogan M. Intravenous Ferric Carboxymaltose for Iron Deficiency Anemia. AAP Grand Rounds 2017, 37: 22-22. DOI: 10.1542/gr.37-2-22.
- Hogan M. Clinical Presentation of Leukemia. AAP Grand Rounds 2016, 36: 70-70. DOI: 10.1542/gr.36-6-70.
- Hogan M. Endocrinopathies in Childhood Cancer Survivors. AAP Grand Rounds 2016, 36: 41-41. DOI: 10.1542/gr.36-4-41.
- Hogan M. Hearing Loss After Cranial Irradiation for Childhood Cancer. AAP Grand Rounds 2016, 36: 32-32. DOI: 10.1542/gr.36-3-32.
- Hogan M. Romiplostim Therapy of Immune Thrombocytopenia. AAP Grand Rounds 2016, 36: 34-34. DOI: 10.1542/gr.36-3-34.
- Hogan M. Cardiovascular Disease Risk After Adolescent & Young Adult Cancer. AAP Grand Rounds 2016, 36: 6-6. DOI: 10.1542/gr.36-1-6.
- Zweidler-McKay PA, Hogan MJ, Jubran R, Black V, Casillas J, Harper J, Malempati S, Margolin J, Felgenhauer J, Sakamoto KM, Franklin J, Shah M, Seibel N, Buchanan G, Vaiselbuh SR, Hastings C, Hilden J, Stork LC. Navigating your career path in pediatric hematology/oncology: On and off the beaten track. Pediatric Blood & Cancer 2016, 63: 1723-1730. PMID: 27295503, DOI: 10.1002/pbc.26094.
- Hogan M. Late Mortality After Childhood Cancer. AAP Grand Rounds 2016, 35: 56-56. DOI: 10.1542/gr.35-5-56.
- Hogan M. Heritable Mutations in Pediatric Cancer. AAP Grand Rounds 2016, 35: 43-43. DOI: 10.1542/gr.35-4-43.
- Hogan M. Pediatric Outcomes After Maternal Cancer During Pregnancy. AAP Grand Rounds 2016, 35: 19-19. DOI: 10.1542/gr.35-2-19.
- Hogan M. Pesticides and Childhood Cancer. AAP Grand Rounds 2015, 34: 66-66. DOI: 10.1542/gr.34-6-66.
- Hogan M. Neurocognitive Deficits After Chemotherapy. AAP Grand Rounds 2015, 34: 53-53. DOI: 10.1542/gr.34-5-53.
- Hogan M. Symptom Distress in Children With Advanced Cancer. AAP Grand Rounds 2015, 34: 42-42. DOI: 10.1542/gr.34-4-42.
- Hogan M. Pulmonary Function in Childhood Cancer Survivors. AAP Grand Rounds 2015, 34: 31-31. DOI: 10.1542/gr.34-3-31.
- Honarpisheh H, Hogan M, Rinder HM, Siddon AJ. Hemoglobinopathy Screening in a 15-Year-old Patient With Anemia. Journal Of Pediatric Hematology/Oncology 2015, 37: 472-473. PMID: 26181419, DOI: 10.1097/mph.0000000000000357.
- Hogan M. Prevalence and Burden of Morbidity in Childhood Cancer Survivors. AAP Grand Rounds 2015, 34: 21-21. DOI: 10.1542/gr.34-2-21.
- Hogan M. Screening for Steroid-Induced Hip Osteonecrosis in Leukemia. AAP Grand Rounds 2015, 33: 66-66. DOI: 10.1542/gr.33-6-66.
- Hogan M. Sun Protection Among Children of Melanoma Survivors. AAP Grand Rounds 2015, 33: 67-67. DOI: 10.1542/gr.33-6-67.
- Hogan M. Emergency Department Visits for Children With Cancer. AAP Grand Rounds 2015, 33: 56-56. DOI: 10.1542/gr.33-5-56.
- Hogan M. Cognitive Function After Hematopoietic Stem Cell Transplantation. AAP Grand Rounds 2015, 33: 34-34. DOI: 10.1542/gr.33-3-34.
- Hogan M. Burden of Central Line Infections in Hematology-Oncology Patients. AAP Grand Rounds 2015, 33: 27-27. DOI: 10.1542/gr.33-3-27.
- Hogan M. Obesity Affects Outcomes in Pediatric Leukemia. AAP Grand Rounds 2015, 33: 18-18. DOI: 10.1542/gr.33-2-18.
- Hogan M. Posttraumatic Stress in Pediatric Cancer Patients. AAP Grand Rounds 2015, 33: 6-6. DOI: 10.1542/gr.33-1-6.
- Hogan M. Late Infections in Childhood Cancer Survivors. AAP Grand Rounds 2015, 33: 5-5. DOI: 10.1542/gr.33-1-5.
- Hogan M. Oral Chemotherapy Adherence in Children With Leukemia. AAP Grand Rounds 2015, 33: 3-3. DOI: 10.1542/gr.33-1-3.
- Hogan M, Ma X, Kadan‐Lottick N. New health conditions identified at a regional childhood cancer survivor clinic visit. Pediatric Blood & Cancer 2012, 60: 682-687. PMID: 23023769, DOI: 10.1002/pbc.24360.
- Staba MJ, Wickham TJ, Kovesdi I, Hallahan DE. Modifications of the fiber in adenovirus vectors increase tropism for malignant glioma models. Cancer Gene Therapy 2000, 7: 13-9. PMID: 10678351, DOI: 10.1038/sj.cgt.7700104.
- Seetharam S, Staba MJ, Schumm LP, Schreiber K, Schreiber H, Kufe DW, Weichselbaum RR. Enhanced eradication of local and distant tumors by genetically produced interleukin-12 and radiation. International Journal Of Oncology 1999, 15: 769-73. PMID: 10493960.
- Mauceri HJ, Hanna NN, Staba MJ, Beckett MA, Kufe DW, Weichselbaum RR. Radiation-inducible gene therapy. Comptes Rendus De L'Académie Des Sciences. Série III, Sciences De La Vie 1999, 322: 225-8. PMID: 10196676.
- Hallahan DE, Staba-Hogan MJ, Virudachalam S, Kolchinsky A. X-ray-induced P-selectin localization to the lumen of tumor blood vessels. Cancer Research 1998, 58: 5216-20. PMID: 9823335.
- Mauceri HJ, Hanna NN, Beckett MA, Gorski DH, Staba MJ, Stellato KA, Bigelow K, Heimann R, Gately S, Dhanabal M, Soff GA, Sukhatme VP, Kufe DW, Weichselbaum RR. Combined effects of angiostatin and ionizing radiation in antitumour therapy. Nature 1998, 394: 287-91. PMID: 9685160, DOI: 10.1038/28412.
- Staba MJ, Mauceri HJ, Kufe DW, Hallahan DE, Weichselbaum RR. Adenoviral TNF-alpha gene therapy and radiation damage tumor vasculature in a human malignant glioma xenograft. Gene Therapy 1998, 5: 293-300. PMID: 9614548, DOI: 10.1038/sj.gt.3300594.
- Staba MJ, Goldman S, Johnson FL, Huttenlocher PR. Allogeneic bone marrow transplantation for Alexander's disease. Bone Marrow Transplantation 1997, 20: 247-9. PMID: 9257894, DOI: 10.1038/sj.bmt.1700871.
- AMA Complete Guide to Your Children’s Health.Editor Traisman ES, Asst. Editors Staba MJ, Judy KR. Random House, New York, 1999.
- Pediatric Specialty CenterSmilow Cancer Hospital at Yale New Haven35 Park StreetNew Haven, CT 06511
- Pediatric Hematology OncologyTrumbull Pediatric Specialty Center5520 Park Avenue, Ste 600Trumbull, CT 06611
- YNHCH Pediatric Specialty Center at GreenwichPediatric Specialty Center500 West Putnam Avenue, Fl 2Greenwich, CT 06830
- Pediatric Specialty CenterSmilow Cancer Hospital at Yale New Haven35 Park StreetNew Haven, CT 06511
- Pediatric Hematology OncologyTrumbull Pediatric Specialty Center5520 Park Avenue, Ste 600Trumbull, CT 06611
- YNHCH Pediatric Specialty Center at GreenwichPediatric Specialty Center500 West Putnam Avenue, Fl 2Greenwich, CT 06830